D
Altamira Therapeutics Ltd.
CYTOF
$0.0585
-$0.0115-16.43%
D
Sell
4/11/2024Upgraded
Altamira Therapeutics Ltd. (CYTO) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the solvency index. Debt to equity declined from 0.02 to 0.01.
Altamira Therapeutics Ltd. (CYTO) was upgraded to D- from E+ on 4/11/2024 due to a large increase in the solvency index. Debt to equity declined from 0.02 to 0.01.
E
Sell
3/14/2023Downgrade
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E+ from D on 03/14/2023.
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E+ from D on 02/08/2023.
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E+ from D on 02/08/2023.
D
Sell
1/23/2023Upgraded
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from D- on 1/23/2023 due to an increase in the growth index. Earnings per share increased from -$5.1055 to -$4.8903, operating cash flow increased 4.21% from -$3.02M to -$2.9M, and EBIT increased 4.21% from -$4.05M to -$3.88M.
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from D- on 1/23/2023 due to an increase in the growth index. Earnings per share increased from -$5.1055 to -$4.8903, operating cash flow increased 4.21% from -$3.02M to -$2.9M, and EBIT increased 4.21% from -$4.05M to -$3.88M.
D
Sell
8/30/2022Downgrade
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 8/30/2022 due to a noticeable decline in the total return index and volatility index.
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 8/30/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and volatility index.
Altamira Therapeutics Ltd. (CYTO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and volatility index.
D
Sell
4/20/2022Downgrade
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index.
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index.
D
Sell
11/23/2021Upgraded
Altamira Therapeutics Ltd. (CYTOF) was upgraded to D from D- on 11/23/2021.
Altamira Therapeutics Ltd. (CYTOF) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index.
Altamira Therapeutics Ltd. (CYTO) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index.
D
Sell
11/30/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 11/30/2020 due to an increase in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 11/30/2020 due to an increase in the volatility index and total return index.
D
Sell
11/12/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 11/12/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 11/12/2020 due to a decline in the volatility index.
D
Sell
10/23/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 10/23/2020 due to an increase in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 10/23/2020 due to an increase in the volatility index and total return index.
D
Sell
10/8/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 10/8/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 10/8/2020 due to a decline in the volatility index.
D
Sell
9/21/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 9/21/2020 due to an increase in the volatility index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 9/21/2020 due to an increase in the volatility index.
D
Sell
9/10/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 9/10/2020 due to a decline in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 9/10/2020 due to a decline in the volatility index and total return index.
D
Sell
8/21/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 8/21/2020 due to an increase in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 8/21/2020 due to an increase in the volatility index and total return index.
D
Sell
8/5/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 8/5/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 8/5/2020 due to a decline in the volatility index.
D
Sell
7/17/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 7/17/2020 due to an increase in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 7/17/2020 due to an increase in the volatility index and total return index.
D
Sell
6/29/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 6/29/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 6/29/2020 due to a decline in the volatility index.
D
Sell
6/11/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 6/11/2020 due to an increase in the volatility index and valuation index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 6/11/2020 due to an increase in the volatility index and valuation index.
D
Sell
5/22/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 5/22/2020 due to a decline in the volatility index and valuation index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 5/22/2020 due to a decline in the volatility index and valuation index.
D
Sell
5/6/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 5/6/2020 due to an increase in the volatility index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 5/6/2020 due to an increase in the volatility index.
D
Sell
5/5/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D- from E+ on 5/5/2020 due to an increase in the volatility index and total return index.
Auris Medical Holding Ltd. (EARS) was upgraded to D- from E+ on 5/5/2020 due to an increase in the volatility index and total return index.
E
Sell
4/20/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to E+ from D- on 4/20/2020 due to a decline in the solvency index and volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to E+ from D- on 4/20/2020 due to a decline in the solvency index and volatility index.
D
Sell
4/9/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 4/9/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 4/9/2020 due to a decline in the volatility index.
D
Sell
3/25/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 3/25/2020 due to an increase in the volatility index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 3/25/2020 due to an increase in the volatility index.
D
Sell
3/5/2020Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 3/5/2020 due to a decline in the volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 3/5/2020 due to a decline in the volatility index.
D
Sell
2/19/2020Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 2/19/2020 due to an increase in the volatility index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 2/19/2020 due to an increase in the volatility index.
D
Sell
11/15/2019Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 11/15/2019 due to a decline in the total return index and volatility index.
Auris Medical Holding Ltd. (EARS) was downgraded to D- from D on 11/15/2019 due to a decline in the total return index and volatility index.
D
Sell
10/15/2019Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 10/15/2019 due to an increase in the solvency index, total return index and volatility index.
Auris Medical Holding Ltd. (EARS) was upgraded to D from D- on 10/15/2019 due to an increase in the solvency index, total return index and volatility index.
D
Sell
5/16/2019Upgraded
Auris Medical Holding Ltd. (EARS) was upgraded to D- from E+ on 5/16/2019 due to a noticeable increase in the valuation index.
Auris Medical Holding Ltd. (EARS) was upgraded to D- from E+ on 5/16/2019 due to a noticeable increase in the valuation index.
E
Sell
5/1/2019Downgrade
Auris Medical Holding Ltd. (EARS) was downgraded to E+ from D- on 5/1/2019 due to a noticeable decline in the valuation index, efficiency index and volatility index. Net income declined 22.42% from -$3.03M to -$3.71M.
Auris Medical Holding Ltd. (EARS) was downgraded to E+ from D- on 5/1/2019 due to a noticeable decline in the valuation index, efficiency index and volatility index. Net income declined 22.42% from -$3.03M to -$3.71M.
D
Sell
11/19/2018Upgraded
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 11/19/2018 due to an increase in the volatility index, efficiency index and valuation index. Total capital increased 1,950.78% from $70.1 to $1.44M, and net income increased 3.13% from -$3.13M to -$3.03M.
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 11/19/2018 due to an increase in the volatility index, efficiency index and valuation index. Total capital increased 1,950.78% from $70.1 to $1.44M, and net income increased 3.13% from -$3.13M to -$3.03M.
E
Sell
3/1/2018Downgrade
Auris Medical Holding AG (EARS) was downgraded to E+ from D- on 3/1/2018 due to a decline in the volatility index and total return index.
Auris Medical Holding AG (EARS) was downgraded to E+ from D- on 3/1/2018 due to a decline in the volatility index and total return index.
D
Sell
11/29/2017Upgraded
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 11/29/2017 due to an increase in the valuation index, solvency index and total return index. Debt to equity declined from 2.17 to -23.23.
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 11/29/2017 due to an increase in the valuation index, solvency index and total return index. Debt to equity declined from 2.17 to -23.23.
E
Sell
8/17/2017Downgrade
Auris Medical Holding AG (EARS) was downgraded to E+ from D- on 8/17/2017 due to a noticeable decline in the solvency index, total return index and volatility index. Debt to equity increased from 1.16 to 2.17, and the quick ratio declined from 3.26 to 2.51.
Auris Medical Holding AG (EARS) was downgraded to E+ from D- on 8/17/2017 due to a noticeable decline in the solvency index, total return index and volatility index. Debt to equity increased from 1.16 to 2.17, and the quick ratio declined from 3.26 to 2.51.
D
Sell
4/22/2016Downgrade
Auris Medical Holding AG (EARS) was downgraded to D- from D on 4/22/2016 due to a decline in the volatility index, total return index and valuation index.
Auris Medical Holding AG (EARS) was downgraded to D- from D on 4/22/2016 due to a decline in the volatility index, total return index and valuation index.
D
Sell
4/7/2016Upgraded
Auris Medical Holding AG (EARS) was upgraded to D from D- on 4/7/2016 due to an increase in the volatility index, valuation index and growth index.
Auris Medical Holding AG (EARS) was upgraded to D from D- on 4/7/2016 due to an increase in the volatility index, valuation index and growth index.
D
Sell
3/16/2016Downgrade
Auris Medical Holding AG (EARS) was downgraded to D- from D on 3/16/2016 due to a noticeable decline in the volatility index, solvency index and valuation index. The quick ratio declined from 9.38 to 8.25.
Auris Medical Holding AG (EARS) was downgraded to D- from D on 3/16/2016 due to a noticeable decline in the volatility index, solvency index and valuation index. The quick ratio declined from 9.38 to 8.25.
D
Sell
9/1/2015Upgraded
Auris Medical Holding AG (EARS) was upgraded to D from D- on 9/1/2015 due to an increase in the solvency index.
Auris Medical Holding AG (EARS) was upgraded to D from D- on 9/1/2015 due to an increase in the solvency index.
D
Sell
5/1/2015Upgraded
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 5/1/2015 due to a large increase in the volatility index, growth index and total return index. Operating cash flow increased 69.28% from -$3.03M to -$5.14M.
Auris Medical Holding AG (EARS) was upgraded to D- from E+ on 5/1/2015 due to a large increase in the volatility index, growth index and total return index. Operating cash flow increased 69.28% from -$3.03M to -$5.14M.
E
Sell
2/2/2015Upgraded
Auris Medical Holding AG (EARS) was upgraded to E+ from E on 2/2/2015 due to an increase in the valuation index.
Auris Medical Holding AG (EARS) was upgraded to E+ from E on 2/2/2015 due to an increase in the valuation index.
E
Sell
12/5/2014Upgraded
Auris Medical Holding AG (EARS) was upgraded to E from E- on 12/5/2014 due to a substantial increase in the efficiency index, total return index and valuation index. Total capital increased 366.24% from $13M to $60.61M.
Auris Medical Holding AG (EARS) was upgraded to E from E- on 12/5/2014 due to a substantial increase in the efficiency index, total return index and valuation index. Total capital increased 366.24% from $13M to $60.61M.
E
Sell
10/29/2014None
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E- from U on 10/29/2014.
Altamira Therapeutics Ltd. (CYTOF) was downgraded to E- from U on 10/29/2014.
OTC PK
04/04/2025 11:26AM Eastern
Quotes delayed
